Jay Venkatesan, Director at Targanta Therapeutics Corp. (TARG), bought 2,667,987 shares at $10.00 ($5.8M) on 2007-10-15, disclosed to the SEC on 2007-10-17.
Open-market purchase of $5.8M TARG by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,092,987 | $0 | 0.0% |
| 2 | $10.00 | 575,000 | $5.8M | 100.0% |
| Total | $2.16 avg | 2,667,987 | $5.8M | 100% |
| Filing → |
| ANGN | BUY | 2022-05-25 | $101K | — | Filing → |
| ANGN | BUY | 2021-12-29 | $1.5M | — | Filing → |
| ANGN | BUY | 2021-12-22 | $9K | — | Filing → |